Functional analysis of EBNA1 protein by using a recombinant EBV with gene replacement

使用基因替换的重组 EBV 进行 EBNA1 蛋白的功能分析

基本信息

  • 批准号:
    14570258
  • 负责人:
  • 金额:
    $ 2.56万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

EBNA1 protein, a viral protein encoded by Epstein-Barr virus (EBY), is a multi-functional protein. It is well known to be essential for the replication and segregation of EBV episomes in latently-infected cells, and it also regulates viral gene expression as a transcriptional activator. We generated a recombinant EBV, designated HMG1-EBNA1 knock-in EBV, in which the EBNA1 gene is replaced with a HMGI-EBNA1 chimeilc gene. The HMG1-EBNA1 chimeric gene encodes an EBNA1 mutant with greatly-impaired transcriptional activity, while keeping the ability of EBNA1 to episomally riiaintain EBV based plasmids. Akata cells harboring wild-type EBV and HMG1-EBNA1 knock-in virus were established. The mixture of wild-type EBV and HMGI-EBNA1 knock-in EBV Was used to infect: EBV-negative Akata cells and cord blood lymphocytes. We found that HMG1-EBNA1 knock-in virus was maintained as episomes in Akata cells. By contrast, the analyses of BACmids that had been rescued from the established lymphoblastoid cell lines revealed that the HMG1-EBNA1. chimeric gene was frequently replaced with the wild-type EBNA1 gene, presumably due to the recombination between HMGI-EBNA1 knock-in EBY and wild-type EBV. These results strongly suggest that the regulation of viral gene expression by EBNA1 as a transactivator is critical, for EBV-induced B cell growth transformation.
EBNA1蛋白是一种由eb病毒(EBY)编码的病毒蛋白,具有多种功能。众所周知,它对于潜伏感染细胞中EBV发作的复制和分离至关重要,并且它还作为转录激活因子调节病毒基因表达。我们生成了重组EBV,命名为HMG1-EBNA1敲入型EBV,其中EBNA1基因被HMGI-EBNA1嵌合基因取代。HMG1-EBNA1嵌合基因编码了一个转录活性严重受损的EBNA1突变体,同时保持了EBNA1特异性维持基于EBV的质粒的能力。建立了携带野生型EBV和HMG1-EBNA1敲入病毒的Akata细胞。用野生型EBV和HMGI-EBNA1敲入型EBV的混合物感染EBV阴性的Akata细胞和脐带血淋巴细胞。我们发现HMG1-EBNA1敲入病毒在Akata细胞中以发作的形式维持。相比之下,从已建立的淋巴母细胞样细胞系中提取的BACmids的分析显示HMG1-EBNA1。嵌合基因经常被野生型EBNA1基因取代,可能是由于HMGI-EBNA1敲入EBY与野生型EBV之间的重组。这些结果强烈提示EBNA1作为反激活因子调控病毒基因表达对于ebv诱导的B细胞生长转化至关重要。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
神田 輝: "EBウイルス(基礎・第4章)"診断と治療社. 8 (2003)
Teru Kanda:“EB 病毒(基础/第 4 章)”诊断和治疗出版 8(2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Teru Kanda: "Production of high-titer EBV recombinants derived from Akata cells using a bacterial artificial chromosome system"J.Virol.. (in press). (2004)
Teru Kanda:“使用细菌人工染色体系统从 Akata 细胞中生产高滴度 EBV 重组体”J.Virol..(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yajima, M., Ahsan, N., Tanaka, M., Takada, K.: "Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system"J.Virol.. 78(13). 7004-7015 (2004)
Yajima, M.、Ahsan, N.、Tanaka, M.、Takada, K.:“使用细菌人工染色体系统从 Akata 细胞中生产高滴度 Epstein-Barr 病毒重组体”J.Virol.. 78(
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Teru Kanda: "Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system"Journal of Virology. 78. 7004-7015 (2004)
Teru Kanda:“使用细菌人工染色体系统从 Akata 细胞中生产高滴度 Epstein-Barr 病毒重组体”《病毒学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KANDA Teru其他文献

KANDA Teru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KANDA Teru', 18)}}的其他基金

Are there any highly oncogenic Epstein-Barr virus strains?
是否存在高致癌性的 Epstein-Barr 病毒株?
  • 批准号:
    15K14391
  • 财政年份:
    2015
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Chromosome tethering mechanism of latently infected Epstein-Barr virus genome
潜伏感染的EB病毒基因组的染色体束缚机制
  • 批准号:
    24590567
  • 财政年份:
    2012
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of host chromosome binding of latently infected Epstein-Barr virus episomes
潜伏感染的EB病毒附加体与宿主染色体结合的机制
  • 批准号:
    21590523
  • 财政年份:
    2008
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of packaging cells for production of BAC-derived recombinant Epstein-Barr virus
开发用于生产 BAC 衍生重组 Epstein-Barr 病毒的包装细胞
  • 批准号:
    18590445
  • 财政年份:
    2006
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Investigating biotic and abiotic conditions impacting apple canker symptom development of nursery plants with latent infection
研究影响潜伏感染苗木苹果溃疡病症状发展的生物和非生物条件
  • 批准号:
    2621580
  • 财政年份:
    2021
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Studentship
Tuberculosis elimination in Australia through targeting latent infection
澳大利亚通过针对潜伏感染消除结核病
  • 批准号:
    nhmrc : 1193750
  • 财政年份:
    2021
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Investigator Grants
Small non-coding RNAs of VZV: role in lytic and latent infection
VZV 小非编码 RNA:在裂解和潜伏感染中的作用
  • 批准号:
    10310489
  • 财政年份:
    2020
  • 资助金额:
    $ 2.56万
  • 项目类别:
Latent infection of Helicobacter cinaedi in bone marrow sustained by reactive sulfur metabolism
活性硫代谢维持的骨髓潜伏感染螺杆菌
  • 批准号:
    19K07554
  • 财政年份:
    2019
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel single genome approaches to determine the mechanisms of HIV latent infection in blood, gut, and lymph nodes
确定血液、肠道和淋巴结中 HIV 潜伏感染机制的新单基因组方法
  • 批准号:
    10611415
  • 财政年份:
    2019
  • 资助金额:
    $ 2.56万
  • 项目类别:
Novel single genome approaches to determine the mechanisms of HIV latent infection in blood, gut, and lymph nodes
确定血液、肠道和淋巴结中 HIV 潜伏感染机制的新单基因组方法
  • 批准号:
    10396456
  • 财政年份:
    2019
  • 资助金额:
    $ 2.56万
  • 项目类别:
Identification and diagnostic application of rabies virus latent infection site using high sensitivity bioimaging method
高灵敏度生物成像方法识别狂犬病病毒潜伏感染部位及诊断应用
  • 批准号:
    19K16001
  • 财政年份:
    2019
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of new therapies targeting latent infection for a radical cure of HIV infectious diseases and AIDS
开发针对潜伏感染的新疗法,以根治艾滋病毒传染病和艾滋病
  • 批准号:
    19K22488
  • 财政年份:
    2019
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Cell stress-mediated changes in the Herpes simplex virus type 1 chromatin structure during reactivation from latent infection
单纯疱疹病毒1型染色质结构在潜伏感染重新激活过程中细胞应激介导的变化
  • 批准号:
    10357923
  • 财政年份:
    2018
  • 资助金额:
    $ 2.56万
  • 项目类别:
Cell stress-mediated changes in the Herpes simplex virus type 1 chromatin structure during reactivation from latent infection
单纯疱疹病毒1型染色质结构在潜伏感染重新激活过程中细胞应激介导的变化
  • 批准号:
    10112968
  • 财政年份:
    2018
  • 资助金额:
    $ 2.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了